Table of Contents

company-logo

Assembly Biosciences, Inc., a clinical-stage biotechnology company, discovers and develops therapeutic candidates for the treatment of hepatitis B virus (HBV) infection in the United States. The company's lead product candidate is Vebicorvir, which as completed Phase 2 clinical trials to treat patients with chronic HBV infection. It is also developing ABI-H3733 that has completed Phase 1a clinical study, and ABI-4334, which is in pre-clinical trials for the treatment of HBV. The company has collaboration agreements with BeiGene, Ltd. and Arbutus Biopharma Corporation; and Antios Therapeutics, Inc. to evaluate a triple combination treatment in patients with chronic hepatitis B virus infection. It also has strategic license agreements with Indiana University Research and Technology Corporation; and Door Pharmaceuticals, LLC. The company was formerly known as Ventrus Biosciences, Inc. and changed its name to Assembly Biosciences, Inc. in June 2014. Assembly Biosciences, Inc. was incorporated in 2005 and is headquartered in South San Francisco, California.

Assembly Biosciences Dividend Announcement

• Assembly Biosciences does not currently offer dividends, we're keeping a close eye on its growth potential and financial developments.
• Stay tuned for updates on Assembly Biosciences dividend policy and future announcements. In the meantime, explore other dividend-yielding opportunities on our website.

Assembly Biosciences Dividend History

Assembly Biosciences Dividend Yield

Assembly Biosciences current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing Assembly Biosciences stock? Use our calculator to estimate your expected dividend yield:

Assembly Biosciences Financial Ratios

P/E ratio-2.31
PEG ratio0.16
P/B ratio3.62
ROE-121.46%
Payout ratio0.00%
Current ratio2.36
Quick ratio2.36
Cash Ratio0.68

Assembly Biosciences Dividend FAQ

Does Assembly Biosciences stock pay dividends?
Assembly Biosciences does not currently pay dividends to its shareholders.
Has Assembly Biosciences ever paid a dividend?
No, Assembly Biosciences has no a history of paying dividends to its shareholders. Assembly Biosciences is not known for its dividend payments.
Why doesn't Assembly Biosciences pay dividends?
There are several potential reasons why Assembly Biosciences would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will Assembly Biosciences ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While Assembly Biosciences has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is Assembly Biosciences a dividend aristocrat?
Assembly Biosciences is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is Assembly Biosciences a dividend king?
Assembly Biosciences is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is Assembly Biosciences a dividend stock?
No, Assembly Biosciences is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy Assembly Biosciences stocks?
To buy Assembly Biosciences you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy Assembly Biosciences stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.